Concepedia

C. Elizabeth Payne

CE

6

Publications

227

Citations

6

H-Index

2005

Active since

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

University of Bristol

C. Elizabeth Payne is an author at Pfizer (United Kingdom) specializing in pharmacotherapy, medicinal chemistry, and drug discovery.

Top concepts

Publications per year

2005–2018

6

Publications

6

A novel selective and orally bioavailable <scp>N</scp> a <scp> <sub>v</sub> </scp> 1.8 channel blocker, <scp>PF</scp> ‐01247324, attenuates nociception and sensory neuron excitability

C. Elizabeth Payne, Adam R. Brown, Jonathon W Theile et al. · British Journal of Pharmacology · 2015 · 96 citations · Full text

Discovery and Optimization of Selective Na <sub>v</sub> 1.8 Modulator Series That Demonstrate Efficacy in Preclinical Models of Pain

Sharan K. Bagal, Peter J. Bungay, Stephen M. Denton et al. · ACS Medicinal Chemistry Letters · 2015 · 40 citations · Full text

Alternative splicing generates a smaller assortment of Ca<sub>V</sub>2.1 transcripts in cerebellar Purkinje cells than in the cerebellum

Srinivasan Kanumilli, Elizabeth Tringham, C. Elizabeth Payne et al. · Physiological Genomics · 2005 · 28 citations

Highly potent and selective NaV1.7 inhibitors for use as intravenous agents and chemical probes

Richard Storer, Andy Pike, Nigel A. Swain et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 27 citations · Full text

, , +12

The discovery and optimization of benzimidazoles as selective NaV1.8 blockers for the treatment of pain

Alan D. Brown, Sharan K. Bagal, Paul G. Blackwell et al. · Bioorganic & Medicinal Chemistry · 2018 · 26 citations · Full text

, , +12

Rows per page

1–5 of 6